Improving care for first episode psychosis in Chile
On Track Chile For First Episode Psychosis
This study is testing a new way to improve care for people in Chile who are experiencing their first episode of psychosis to see if it helps them feel better compared to the usual treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 15 Years to 35 Years |
| Sex | All |
| Sponsor | University of Chile Academic / other |
| Locations | 1 site (Santiago) |
| Trial ID | NCT04247711 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance the treatment of individuals experiencing First Episode Psychosis (FEP) in Chile by implementing evidence-based practices in community mental health clinics. It focuses on the integration of a coordinated specialty care model within the existing public health framework to ensure that patients receive timely and effective interventions. The study will compare the outcomes of a new intervention program against usual FEP services to assess improvements in patient care and symptom management. By leveraging Chile's unique position as a low-and-middle-income country with a policy framework for FEP services, the study seeks to address gaps in mental health care delivery.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with first episode psychosis who are receiving services at participating outpatient mental health clinics in Chile.
Not a fit: Patients with psychosis due solely to another medical condition or those with non-psychiatric medical conditions that impair functioning may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve the quality of care and outcomes for patients experiencing first episode psychosis.
How similar studies have performed: Other studies in high-income countries have shown success with similar coordinated specialty care approaches for first episode psychosis, indicating potential for positive outcomes in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals who have FEP (First Episode Psychosis) * Individuals who are receiving services at a participating outpatient mental health clinic. * Individuals who meet ICT-10 criteria for a diagnosis of schizophrenia, schizophreniform, schizoaffective disorder, delusional disorder, brief psychotic disorder, or psychosis not otherwise specified. * Individuals who have the capacity to provide fully informed consent. (For those under age 18, capacity to provide assent plus informed consent of parent/guardian.) * Individuals who are able to participate in research assessments in Spanish Exclusion Criteria: * Individuals who have a non-psychiatric medical condition that impairs functioning. * Individuals who have a psychosis due solely to another medical condition. * Individuals who have a psychosis due to a developmental disability.
Where this trial is running
Santiago
- CESAM San Joaquín — Santiago, Chile (Recruiting)
Study contacts
- Principal investigator: Ruben Alvarado, MD PhD — University of Chile
- Study coordinator: Ruben Alvarado, MD PhD
- Email: ralvarado@med.uchile.cl
- Phone: 562 2 903 0000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.